Glp 1 T 2d denied as not medically necessary by Cigna?

Cigna's specific coverage criteria for glp1 t2d are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Cigna Denied This GLP-1 for Type 2 Diabetes: Medical Necessity

A medical-necessity denial means Cigna reviewed the clinical information submitted and concluded that the prescribed GLP-1 medication was not demonstrated to be medically necessary under its coverage criteria for type 2 diabetes management. This is one of the most common — and most successfully appealed — denial types for this drug class. It usually means the submitted documentation was incomplete, the clinical criteria in Cigna's policy were not addressed point by point, or the prescriber's rationale was not clearly tied to the specific requirements in Cigna's medical policy.

## Why It Is Appealable

Medical-necessity determinations are clinical judgments, and Cigna's internal reviewer may have applied criteria differently than your treating physician. On appeal, you have the right to have your full clinical record reviewed by an independent clinician. GLP-1 receptor agonists are endorsed for type 2 diabetes management by major diabetes guideline organizations, and Cigna's own coverage policies generally recognize this class when documentation thresholds are met. A detailed, criteria-matched appeal that directly addresses each policy requirement significantly improves the likelihood of reversal.

## Federal Appeal Framework

• Internal appeal (ACA §2719 / ERISA §503): You have the right to a full and fair internal review. File your written appeal within the deadline on the denial notice. You are entitled to receive the clinical criteria Cigna used, the name of the reviewing clinician, and all records Cigna relied upon.
• Peer-to-peer review: Your prescriber should request a peer-to-peer conversation with Cigna's medical director before or during the appeal. This frequently results in reversal without a formal appeal proceeding.
• External review: If the internal appeal is denied, independent external review under ACA §2719 is available within approximately four months of the denial. The external reviewer is an independent clinician who applies their own clinical judgment, not Cigna's internal policies.

## Documentation to Gather

1. Cigna's medical policy: Download the current Cigna coverage policy for GLP-1 therapy in type 2 diabetes. List every medical-necessity criterion exactly as written — this becomes your appeal checklist. 2. Diagnosis documentation: Chart notes confirming your type 2 diabetes diagnosis, duration, and current clinical status. 3. Prior treatment history: Dated records of all prior diabetes medications tried, with duration of use and documented reasons for discontinuation or inadequate response (side effects, subtherapeutic glycemic control, etc.). 4. Current clinical severity: Recent lab results, HbA1c trend, and any diabetes-related complications or comorbidities your prescriber identified as relevant to the necessity determination. 5. Prescriber medical-necessity letter: A structured letter — ideally written against Cigna's policy criteria — addressing each requirement individually with specific chart references.

## Criteria-Mapping Structure

Number each criterion from Cigna's medical policy. For each one, write a one-paragraph response citing the specific chart document — with date and provider name — that satisfies it. Attach every referenced document as a labeled exhibit. Your cover letter should open by stating: "This appeal addresses each of Cigna's [N] medical-necessity criteria in order" and then reference the exhibits. This format makes it procedurally difficult for Cigna to deny again without explaining why each criterion was not met.